Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

15-Jun-16 - 13-Jun-17
Buy Ratio:41%

Down

# Net Buyers:132
# Net Sellers:189

Previous 52 Weeks

17-Jun-15 - 14-Jun-16
Buy Ratio:43%
# Net Buyers:148
# Net Sellers:197
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
China Biologic Products, Inc.($21.43M)$1.55B  
Zoetis Inc.($8.59M)$778.93M  
Colucid Pharmaceuticals, Inc.$713.06M$714.43M  
Juno Therapeutics, Inc.($11.43M)$435.66M  
United Therapeutics Corp($33.27M)$142.74M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$713.06M$714.43M  
Tobira Therapeutics, Inc.$69.59M$75.03M  
Abbott Laboratories$24.90M$58.08M  
Agios Pharmaceuticals Inc$4.73M$29.57M  
Alnylam Pharmaceuticals, Inc.$10.89M$23.86M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.84B)($1.83B)  
Seattle Genetics Inc /wa$114.27M($325.57M)  
Incyte Corp($53.89M)($264.48M)  
Catalent, Inc.($412.05M)($178.99M)  
Relypsa Inc($140.39M)($129.17M)  
New Net Sellers
CompanyNet Buy AmountChange
Incyte Corp($53.89M)($264.48M)  
Global Blood Therapeutics, Inc.($96.45M)($96.51M)  
Biogen Inc.($370.35K)($75.62M)  
Esperion Therapeutics, Inc.($49.21M)($49.55M)  
Exelixis, Inc.($40.79M)($40.94M)